IQV
Price
$138.07
Change
+$0.78 (+0.57%)
Updated
May 22, 04:59 PM (EDT)
Capitalization
45.3B
68 days until earnings call
NEOG
Price
$6.19
Change
-$0.03 (-0.48%)
Updated
May 22, 04:59 PM (EDT)
Capitalization
3.42B
68 days until earnings call
Interact to see
Advertisement

IQV vs NEOG

Header iconIQV vs NEOG Comparison
Open Charts IQV vs NEOGBanner chart's image
IQVIA Holdings
Price$138.07
Change+$0.78 (+0.57%)
Volume$16.36K
Capitalization45.3B
Neogen
Price$6.19
Change-$0.03 (-0.48%)
Volume$95.04K
Capitalization3.42B
IQV vs NEOG Comparison Chart
Loading...
IQV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NEOG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IQV vs. NEOG commentary
May 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IQV is a Buy and NEOG is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
May 23, 2025
Stock price -- (IQV: $137.29 vs. NEOG: $6.22)
Brand notoriety: IQV: Notable vs. NEOG: Not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: IQV: 125% vs. NEOG: 61%
Market capitalization -- IQV: $45.3B vs. NEOG: $3.42B
IQV [@Medical Specialties] is valued at $45.3B. NEOG’s [@Medical Specialties] market capitalization is $3.42B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.5B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IQV’s FA Score shows that 0 FA rating(s) are green whileNEOG’s FA Score has 1 green FA rating(s).

  • IQV’s FA Score: 0 green, 5 red.
  • NEOG’s FA Score: 1 green, 4 red.
According to our system of comparison, NEOG is a better buy in the long-term than IQV.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IQV’s TA Score shows that 4 TA indicator(s) are bullish while NEOG’s TA Score has 5 bullish TA indicator(s).

  • IQV’s TA Score: 4 bullish, 4 bearish.
  • NEOG’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, NEOG is a better buy in the short-term than IQV.

Price Growth

IQV (@Medical Specialties) experienced а -3.19% price change this week, while NEOG (@Medical Specialties) price change was -2.51% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.26%. For the same industry, the average monthly price growth was +6.83%, and the average quarterly price growth was -0.38%.

Reported Earning Dates

IQV is expected to report earnings on Jul 29, 2025.

NEOG is expected to report earnings on Jul 29, 2025.

Industries' Descriptions

@Medical Specialties (+0.26% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IQV($45.3B) has a higher market cap than NEOG($3.42B). NEOG has higher P/E ratio than IQV: NEOG (150.80) vs IQV (34.14). IQV YTD gains are higher at: -30.136 vs. NEOG (-48.764). IQV has higher annual earnings (EBITDA): 3.26B vs. NEOG (189M). IQV has more cash in the bank: 1.5B vs. NEOG (230M). NEOG has less debt than IQV: NEOG (889M) vs IQV (13.9B). IQV has higher revenues than NEOG: IQV (15B) vs NEOG (919M).
IQVNEOGIQV / NEOG
Capitalization45.3B3.42B1,326%
EBITDA3.26B189M1,723%
Gain YTD-30.136-48.76462%
P/E Ratio34.14150.8023%
Revenue15B919M1,632%
Total Cash1.5B230M650%
Total Debt13.9B889M1,564%
FUNDAMENTALS RATINGS
IQV vs NEOG: Fundamental Ratings
IQV
NEOG
OUTLOOK RATING
1..100
816
VALUATION
overvalued / fair valued / undervalued
1..100
70
Overvalued
96
Overvalued
PROFIT vs RISK RATING
1..100
94100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
6462
P/E GROWTH RATING
1..100
902
SEASONALITY SCORE
1..100
5075

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IQV's Valuation (70) in the Servicestothe Health Industry industry is in the same range as NEOG (96) in the Medical Specialties industry. This means that IQV’s stock grew similarly to NEOG’s over the last 12 months.

IQV's Profit vs Risk Rating (94) in the Servicestothe Health Industry industry is in the same range as NEOG (100) in the Medical Specialties industry. This means that IQV’s stock grew similarly to NEOG’s over the last 12 months.

IQV's SMR Rating (100) in the Servicestothe Health Industry industry is in the same range as NEOG (100) in the Medical Specialties industry. This means that IQV’s stock grew similarly to NEOG’s over the last 12 months.

NEOG's Price Growth Rating (62) in the Medical Specialties industry is in the same range as IQV (64) in the Servicestothe Health Industry industry. This means that NEOG’s stock grew similarly to IQV’s over the last 12 months.

NEOG's P/E Growth Rating (2) in the Medical Specialties industry is significantly better than the same rating for IQV (90) in the Servicestothe Health Industry industry. This means that NEOG’s stock grew significantly faster than IQV’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IQVNEOG
RSI
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
61%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
65%
Bearish Trend 2 days ago
76%
Momentum
ODDS (%)
Bearish Trend 2 days ago
56%
Bullish Trend 2 days ago
59%
MACD
ODDS (%)
Bearish Trend 2 days ago
64%
Bullish Trend 2 days ago
60%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
61%
Bearish Trend 2 days ago
77%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
66%
Bullish Trend 2 days ago
65%
Advances
ODDS (%)
Bullish Trend 3 days ago
60%
Bullish Trend 7 days ago
66%
Declines
ODDS (%)
Bearish Trend 8 days ago
62%
Bearish Trend 3 days ago
78%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
70%
Bearish Trend 2 days ago
74%
Aroon
ODDS (%)
Bearish Trend 2 days ago
60%
Bullish Trend 2 days ago
71%
View a ticker or compare two or three
Interact to see
Advertisement
IQV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NEOG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
JBL165.20-2.31
-1.38%
Jabil
IOSP85.96-2.37
-2.68%
Innospec
YMAB4.10-0.13
-3.07%
Y-mAbs Therapeutics
NPWR1.50-0.09
-5.66%
NET Power
CLRB0.25-0.02
-5.68%
Cellectar Biosciences

NEOG and

Correlation & Price change

A.I.dvisor indicates that over the last year, NEOG has been loosely correlated with RVTY. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if NEOG jumps, then RVTY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NEOG
1D Price
Change %
NEOG100%
+0.32%
RVTY - NEOG
42%
Loosely correlated
-4.01%
IQV - NEOG
40%
Loosely correlated
-5.28%
CNMD - NEOG
40%
Loosely correlated
-4.06%
SHC - NEOG
39%
Loosely correlated
-3.74%
RDNT - NEOG
38%
Loosely correlated
-3.49%
More